GGrantIndex
← Search

ADVL0214: PHASE I STUDY OF SINGLE AGENT OSI-774 FOLLOWED OSI-774 W TEMOZOLOMIDE

$9,300M01FY2005RRNIH

Children'S Hosp Pittsburgh/Upmc Hlth Sys, Pittsburgh PA

Investigators

Linked publications & trials

View original record on NIH RePORTER →
ADVL0214: PHASE I STUDY OF SINGLE AGENT OSI-774 FOLLOWED OSI-774 W TEMOZOLOMIDE · GrantIndex